NRG GY009 Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

February 19, 2019
https://clinicaltrials.gov/ct2/show/NCT02839707
Cancer - Ovarian
Principal Investigator: Rabbie K Hanna, MD
GYNECOLOGIC, CANCER, RECURRENT, OVARIAN, FALLOPIAN, FALLOPIAN TUBE, PERITONEAL
Accepting Participants